Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 853-858

  Lebtahi, Rachida ^a   Cadiot, Guillaume ^a   Sarda, Laure ^a   Daou, Doumit ^a   Faraggi, Marc ^a   Petegnief, Yolande ^a   Mignon, Michel ^a   Le Guludec, Dominique ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Gastroenteropancreatic tumors; Neuroendocrine tumors; Somatostatin receptor scintigraphy

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; BONE METASTASIS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METASTASIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RADIOGRAPHY; SCINTIGRAPHY;

CARCINOID TUMOR; CASE-CONTROL STUDIES; DIAGNOSTIC IMAGING; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INDIUM RADIOISOTOPES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; ZOLLINGER-ELLISON SYNDROME;

EID: 0030970530     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mignon M, Bonfils S. Diagnosis and treatment of Zollinger-Ellison syndrome. Baillère's Clin Gastroenterol 1988;2:677-698.
2. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome. Ann Surg 1992;215:8-18.
3. Fraker DL, Norton JA, Alexander HR, Venzon DJ, Jensen RT. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 1994;220:320-330.
4. Kvols LK, Reubi J-C. Metastatic carcinoid and the malignant carcinoid syndrome. Acta Oncol 1993;32:197-201.
5. Akerström G, Makridis C, Johansson H. Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol 1991;30:547-553.
6. Norton JA. Surgical treatment of islet cell tumors with special emphasis on operative ultrasound. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: recent advances. Basel, Switzerland: Karger; 1995;309-332.
7. Rösch T, Lightdate CJ, Botet JF, et al. Localization of pancreatic endocrine tumors by endoscopie ultrasonography. N Engl J Med 1992;326:1721-1727.
8. Ruszniewski P, Amouyal P, Amouyal G, Cadiot G, Mignon M, Bernades P. Endocrine tumors of the pancreatic area: localization by endoscopie ultrasonography. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: recent advances. Basel, Switzerland: Karger; 1995;258-267.
9. Krenning EP, Bakker WH, Breeman WAP, et al. Localization of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1989;i:242-245.
10. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin receptor imaging in the localization of endocrine tumors. N Engl J Med 1990;323:1246-1249.
11. 123I-Thyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
12. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrin Rev 1991;12:450-482.
13. Reubi JC, Häcki WH, Lamberts SWJ. Hormones producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab 1987;65: 1127-1134.
14. Lambert SWJ, Holland LJ, Van Koetsveld PM, et al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab 1990;71:566-574.
15. Reubi JC, Kvols L, Krenning EP, Lamberts SWJ. Distribution of somatostatin receptor in normal and tumor tissue. Metabolism 1990;30(suppl 2):78-81.
16. Reubi JC, Kvols L, Krenning EP, Lamberts SWJ. In vivo in vitro detection of somatostatin receptors in human malignant tissues. Acta Oncol 1991;30:463-468.
17. Krenning EP, Kwekkeboom DJ, de Jong M, et al. Essential of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide. Semin Oncol 1994;21:6-14.
18. Lamberts SWJ, Reubi JC, Krenning EP. Somatostatin and the concept of peptide receptor scintigraphy in oncology. Semin Oncol 1994;21:1-5.
19. Lamberts SWJ, Chayvialle J-A, Krenning EP. The visualization of gastroentcropancreatic tumors. Metabolism 1992;9(suppl):111-115.
20. Kwekkeboom DJ, Krenning EP, Bakker WH, et al. Somatostatin receptor scintigraphy in carcinoid tumors. Eur J Nucl Med 1993;20:283-292.
21. Kvols LK, Brown ML, O'Connor MK, et al. Evaluation of a radiolabeled somatostatin analog (I-123 octrotide) in the detection and localization of carcinoid and islet cell tumors. Radiology 1993;187:129-133.
22. 111In-pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res 1993;27(suppl):28-35.
23. De Kerviler E, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M. GRESZE: Somatostatin receptor scintigraphy in 48 patients with the Zollinger-Ellison syndrome. Eur J Nucl Med 1994;21:1191-1197.
24. 111Indium pentetreotide scintigraphy. Semin Oncol 1994;21:15-20.
25. Jamar F, Fiasse R, Leners N, Pauwels S. Somatostatin receptor imaging with Indium-111-pentreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med 1995;36:542-549.
26. Kwekkeboom DJ, Krenning EP, Oei HY, et al. Use of radiolabeled somatostatin to localize islet cell tumors. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: recent advances. Basel, Switzerland: Karger; 1995:298-308.
27. Wiedenmann B, Bader HM, Scherubl et al. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy. Semin Oncol 1994;21:29-32.
28. Schirmer WJ, Melvin WS, Rush RM, et al. Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma. Surgery 1995;118: 1105-1113.
29. Ahlman H, Tisell L-E, Wanberg B, et al. Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector. Semin Oncol 1994;21:21-28.
30. Krenning EP, Kwekkeboom DJ, Pauwels S, et al. Somatostatin receptor scintigraphy. In: Freeman LM, cd. Nuclear medicine annual. New York: Raven Press: 1995:1-50.
31. Lamberts SWJ, Reubi JC, Krenning EP. The role of somatostatin analogs in the control of tumor growth. Semin Oncol 1994;21:61-64.
32. Kvols LK. Medical oncology considerations in patients with metastatic neuroendocrine carcinomas. Semin Oncol 1994;21:56-60.
33. Wiseman GA, Kvols LK. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogs. Semin Nucl Med 1995;25:272-278.
34. Lamberts SWJ, Van Der Lely A-J, De Herder WW, et al. Octreotide. N Engl J Med 1996;334:246-254.
35. Woltering EA, Barrie R, O'Dorisio TM, O'Dorisio MS, Nance R, Cook DM. Detection of occult gastrinomas with iodine-125-labeled lanreotide and intraoperative gamme detection. Surgery 1994;116:1139-1147.